Harmony Biosciences Holdings, Inc. Operating Income Margin for the Trailing 12 Months (TTM) ending March 31, 2025: 26.18%

Harmony Biosciences Holdings, Inc. Operating Income Margin is 26.18% for the Trailing 12 Months (TTM) ending March 31, 2025, a -20.60% change year over year. Operating Income Ratio is the proportion of a company's operating income to its net sales, measuring the efficiency of its core business operations in generating profits.
  • Harmony Biosciences Holdings, Inc. Operating Income Margin for the Trailing 12 Months (TTM) ending March 31, 2024 was 32.98%, a 16.90% change year over year.
  • Harmony Biosciences Holdings, Inc. Operating Income Margin for the Trailing 12 Months (TTM) ending March 31, 2023 was 28.21%, a -7.12% change year over year.
  • Harmony Biosciences Holdings, Inc. Operating Income Margin for the Trailing 12 Months (TTM) ending March 31, 2022 was 30.37%, a 51.60% change year over year.
  • Harmony Biosciences Holdings, Inc. Operating Income Margin for the Trailing 12 Months (TTM) ending March 31, 2021 was 20.03%, a -105.60% change year over year.
Key Data
Date Operating Income Margin Gross Profit Margin EBIT Margin EBITDA Margin